ESC Guideline Recommendations for Antidepressant Use with Anticoagulants in Older Adults

1. Guideline Recommendations

The European Society of Cardiology (ESC) advises that combinations of oral anticoagulants with either SNRIs or SSRIs should be avoided in older adults with cardiovascular disease; when antidepressant therapy is unavoidable, SNRIs are preferred because they carry the lowest bleeding risk among antidepressants. [1][2][3][4]5

Patients ≥ 65 years who have a history of gastrointestinal ulcer, are receiving anticoagulants or antiplatelet agents, or have chronic kidney disease experience a compounded risk of bleeding when an antidepressant is added. [1][6]
Additional independent risk factors for gastrointestinal bleeding include age ≥ 75 years, prior peptic ulcer disease, previous GI bleeding, and concurrent use of anticoagulants, antiplatelet drugs, or systemic glucocorticoids. [3][5]

In high‑risk patients where an antidepressant cannot be omitted, concomitant proton‑pump inhibitor (PPI) therapy should be strongly considered to provide gastro‑protection. [3][7][8][9]6
Specific indications for adding a PPI include:

Close monitoring for signs of bleeding (e.g., occult blood, melena, hematuria) is recommended during the first six months after initiating an antidepressant in this population. [1][2]
Antidepressant therapy should be avoided in patients with active bleeding or in those judged unfit for adequate monitoring. [1][4]

Selective serotonin reuptake inhibitors (SSRIs) markedly inhibit serotonin uptake in platelets, leading to impaired platelet aggregation and increased bleeding tendency. 10

The concurrent use of NSAIDs, antiplatelet agents, or warfarin markedly heightens bleeding risk irrespective of whether an SNRI or SSRI is prescribed. [11][10]
In patients with creatinine clearance < 30 mL/min who are on anticoagulants, the bleeding risk is further elevated, necessitating dose adjustments of the anticoagulant therapy. [1][2]